Bill Roth, general manager and managing partner of IntegriChain’s consulting business, previews his new six-part series by ...

Although he typically revises his macro framework only once every decade or more, Roth explained that the current environment ...

Last year, pharmaceutical companies spent over $8.1 billion on marketing campaigns, allocating over half of that to reach healthcare providers (HCPs). As the digital era retains its post-pandemic grip ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era.  | Pharma marketers enter 2026 asking where DTC fits in the ...

With penalties to pharma companies for violating the Physician Payments Sunshine Act potentially ranging into the millions of dollars, adhering to the act is a priority. But when it comes to marketing ...

LONDON--(BUSINESS WIRE)--As coronavirus continues to wreak havoc across industries, Quantzig’s sales analytics experts analyze the recent challenges in the pharmaceutical industry and explain why a ...

Market entry decisions in pharmaceuticals carry extraordinary weight. Each choice influences billions in investment, years of development effort, and ultimately patient access to innovative therapies.

DALLAS--(BUSINESS WIRE)--For over two decades, Pharmaceutical Strategies Group (“PSG”) has provided independent, research-driven insights into pharmacy benefit manager (PBM) performance through its ...